161 related articles for article (PubMed ID: 30055974)
1. Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia.
Salvador C; Entenmann A; Salvador R; Niederwanger A; Crazzolara R; Kropshofer G
J Clin Lipidol; 2018; 12(5):1260-1266. PubMed ID: 30055974
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-chain omega-3 polyunsaturated fatty acids on cardiometabolic factors in children with acute lymphoblastic leukemia undergoing treatment: a secondary analysis of a randomized controlled trial.
Barbosa-Cortes L; Atilano-Miguel S; Martin-Trejo JA; Jiménez-Aguayo E; Martínez-Becerril FI; López-Alarcón M; Mejía Aranguré JM; Maldonado-Hernández J; Delgadillo-Portillo S; Guzmán-Castro B; Delgadillo-Portillo J; Añoveros-Barrera A; Solis-Labastida KA; Bautista-Martinez BA; Juárez-Moya A; Hernández-Piñón Z; Espinoza Hernández LE; Núñez-Villegas NN; Jiménez-Hernández E; Pérez-Casillas RX
Front Endocrinol (Lausanne); 2023; 14():1120364. PubMed ID: 37124732
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effects of omega-3 polyunsaturated fatty acids and Olbetam (Acipimox) in the treatment of hypertriglyceridemia].
Zák A; Zeman M; Vítková D
Cas Lek Cesk; 1994 Dec; 133(24):755-8. PubMed ID: 7834677
[TBL] [Abstract][Full Text] [Related]
4. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia.
Hadigan C; Liebau J; Torriani M; Andersen R; Grinspoon S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4438-44. PubMed ID: 16940448
[TBL] [Abstract][Full Text] [Related]
5. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
Yeshurun D; Hamood H; Morad N; Naschitz J
Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
[TBL] [Abstract][Full Text] [Related]
6. Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity.
Del-Río-Navarro BE; Miranda-Lora AL; Huang F; Hall-Mondragon MS; Leija-Martínez JJ
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):811-819. PubMed ID: 31271554
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
[TBL] [Abstract][Full Text] [Related]
8. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
9. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH
J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690
[TBL] [Abstract][Full Text] [Related]
11. Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines.
Baxter CL; Martin EG; Marwa BM; Pacaud D; Cummings EA
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):978-982. PubMed ID: 37403553
[TBL] [Abstract][Full Text] [Related]
12. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
[TBL] [Abstract][Full Text] [Related]
13. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.
Goldenberg NM; Wang P; Glueck CJ
Clin Chim Acta; 2003 Jun; 332(1-2):11-9. PubMed ID: 12763274
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acid therapy dose-dependently and significantly decreased triglycerides and improved flow-mediated dilation, however, did not significantly improve insulin sensitivity in patients with hypertriglyceridemia.
Oh PC; Koh KK; Sakuma I; Lim S; Lee Y; Lee S; Lee K; Han SH; Shin EK
Int J Cardiol; 2014 Oct; 176(3):696-702. PubMed ID: 25147070
[TBL] [Abstract][Full Text] [Related]
15. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians.
Bays H
Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782
[TBL] [Abstract][Full Text] [Related]
16. Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia.
Stacpoole PW; Alig J; Ammon L; Crockett SE
Metabolism; 1989 Oct; 38(10):946-56. PubMed ID: 2677610
[TBL] [Abstract][Full Text] [Related]
17. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemic acute pancreatitis during pregnancy: prevention with diet therapy and omega-3 fatty acids in the following pregnancy.
Takaishi K; Miyoshi J; Matsumura T; Honda R; Ohba T; Katabuchi H
Nutrition; 2009; 25(11-12):1094-7. PubMed ID: 19524405
[TBL] [Abstract][Full Text] [Related]
19. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
20. Omega-3-carboxylic acid (Epanova) for hypertriglyceridemia.
Zhao A; Lam S
Cardiol Rev; 2015; 23(3):148-52. PubMed ID: 25580706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
